July Health News: New Guidelines for High Risk HIV Population Management; FDA Reclassification of Sunlamp Products; HPV Vaccine and Blood Clot Risk

*  1.  Prophylactic Antiretroviral Drugs for HIV High Risk  Population – New Guidelines from the World Health Organization (WHO)* **In the newly released Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations, WHO strongly recommended for the HIV high risk groups to take antiretroviral medication such as Truvada as a pre-exposure prophylaxis …